In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis
- 1 March 2001
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 17 (3) , 229-231
- https://doi.org/10.1016/s0924-8579(00)00337-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infectionThe Lancet, 1997
- The Clinical Use of Fluoroquinolones for the Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 1997
- Activity of Quinolones against MycobacteriaDrugs, 1995
- Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospitalArchives of internal medicine (1960), 1994
- Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutationsAntimicrobial Agents and Chemotherapy, 1994
- Early Bactericidal and Sterilizing Activities of Ciprofloxacin in Pulmonary TuberculosisAmerican Review of Respiratory Disease, 1993
- Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1993
- In VitroActivity of the New Quinolone Lomefloxacin againstMycobacterium tuberculosisAmerican Review of Respiratory Disease, 1992
- Newly documented antimicrobial activity of quinolonesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Minimal Inhibitory Concentrations of Rifabutin, Ciprofloxacin, and Ofloxacin againstMycobacterium tuberculosisIsolated before Treatment of Patients in TaiwanAmerican Review of Respiratory Disease, 1989